Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT.
Angelo MaggioTiziana RancatiMarco GattiDomenico CanteBarbara AvuzziCinzia BianconiFabio BadenchiniBruno FarinaPaolo FerrariTommaso GiandiniGiuseppe GirelliValeria LandoniAlessandro MagliEugenia MorettiEdoardo PetrucciPaolo SalmoiraghiGiuseppe SanguinetiElisa VillaJustyna Magdalena WaskiewiczAlessia GuarneriRiccardo ValdagniClaudio FiorinoCesare CozzariniPublished in: Current oncology (Toronto, Ont.) (2024)
In this prospective, longitudinal, observational study, high radiation IMRT doses delivered for PCa led to a temporary worsening of QoL, which tended to be completely resolved at six months. Such transient worsening was mostly associated with acute GI/GU toxicity, WPRT, and higher prescription doses.
Keyphrases
- prostate cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- liver failure
- cross sectional
- radiation induced
- radiation therapy
- oxidative stress
- squamous cell carcinoma
- respiratory failure
- drug induced
- patient reported outcomes
- hepatitis b virus
- brain injury
- subarachnoid hemorrhage
- cerebral ischemia
- aortic dissection
- oxide nanoparticles